Arrowhead Pharmaceuticals, Inc. (ARWR): Price and Financial Metrics

Arrowhead Pharmaceuticals, Inc. (ARWR): $33.61

0.33 (+0.99%)

POWR Rating

Component Grades













Add ARWR to Watchlist
Sign Up

Industry: Biotech



in industry


  • ARWR scores best on the Value dimension, with a Value rank ahead of 72.38% of US stocks.
  • The strongest trend for ARWR is in Growth, which has been heading up over the past 177 days.
  • ARWR ranks lowest in Stability; there it ranks in the 16th percentile.

ARWR Stock Summary

  • ARWR's price/sales ratio is 14.5; that's higher than the P/S ratio of 92.08% of US stocks.
  • With a year-over-year growth in debt of 219.34%, ARROWHEAD PHARMACEUTICALS INC's debt growth rate surpasses 93.51% of about US stocks.
  • Revenue growth over the past 12 months for ARROWHEAD PHARMACEUTICALS INC comes in at 75.89%, a number that bests 88.76% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to ARROWHEAD PHARMACEUTICALS INC, a group of peers worth examining would be AVIR, ALLO, TSP, INDI, and INMB.
  • ARWR's SEC filings can be seen here. And to visit ARROWHEAD PHARMACEUTICALS INC's official web site, go to

ARWR Valuation Summary

  • ARWR's price/sales ratio is 14.7; this is 617.07% higher than that of the median Healthcare stock.
  • Over the past 226 months, ARWR's price/earnings ratio has gone NA NA.

Below are key valuation metrics over time for ARWR.

Stock Date P/S P/B P/E EV/EBIT
ARWR 2023-01-20 14.7 9.0 -20.3 -20.0
ARWR 2023-01-19 14.8 9.0 -20.4 -20.1
ARWR 2023-01-18 15.7 9.6 -21.7 -21.4
ARWR 2023-01-17 16.1 9.8 -22.2 -21.9
ARWR 2023-01-13 16.0 9.8 -22.2 -21.9
ARWR 2023-01-12 15.8 9.6 -21.8 -21.5

ARWR Growth Metrics

    Its 4 year net income to common stockholders growth rate is now at 115.95%.
  • Its 2 year net income to common stockholders growth rate is now at -1273.02%.
  • The 2 year revenue growth rate now stands at 89.55%.
Over the past 33 months, ARWR's revenue has gone up $79,638,740.

The table below shows ARWR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 243.231 -136.131 -176.063
2022-06-30 249.939 -91.581 -153.926
2022-03-31 263.418 -52.344 -111.804
2021-12-31 144.424 148.799 -182.988
2021-09-30 138.287 171.224 -140.848
2021-06-30 107.6379 184.491 -125.9067

ARWR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ARWR has a Quality Grade of C, ranking ahead of 55.82% of graded US stocks.
  • ARWR's asset turnover comes in at 0.171 -- ranking 211th of 682 Pharmaceutical Products stocks.
  • COLL, CRBP, and VBIV are the stocks whose asset turnover ratios are most correlated with ARWR.

The table below shows ARWR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.171 1 -0.460
2021-03-31 0.153 1 -0.385
2020-12-31 0.149 1 -0.363
2020-09-30 0.158 1 -0.397
2020-06-30 0.241 1 -0.218
2020-03-31 0.303 1 0.013

ARWR Price Target

For more insight on analysts targets of ARWR, see our ARWR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $87.92 Average Broker Recommendation 1.59 (Moderate Buy)

ARWR Stock Price Chart Interactive Chart >

Price chart for ARWR

ARWR Price/Volume Stats

Current price $33.61 52-week high $56.25
Prev. close $33.28 52-week low $26.81
Day low $33.21 Volume 427,100
Day high $34.08 Avg. volume 1,146,644
50-day MA $33.66 Dividend yield N/A
200-day MA $36.46 Market Cap 3.59B

Arrowhead Pharmaceuticals, Inc. (ARWR) Company Bio

Arrowhead Pharmaceuticals is a biopharmaceutical company developing targeted RNAi therapeutics. The company was founded in 1989 and is based in Pasadena, California.

ARWR Latest News Stream

Event/Time News Detail
Loading, please wait...

ARWR Latest Social Stream

Loading social stream, please wait...

View Full ARWR Social Stream

Latest ARWR News From Around the Web

Below are the latest news stories about ARROWHEAD PHARMACEUTICALS INC that investors may wish to consider to help them evaluate ARWR as an investment opportunity.

Arrowhead Pharmaceuticals to Webcast Fiscal 2023 First Quarter Results

PASADENA, Calif., January 25, 2023--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on February 6, 2023, at 4:30 p.m. ET to discuss its financial results for the fiscal 2023 first quarter ended December 31, 2022.

Yahoo | January 25, 2023

A Look At The Intrinsic Value Of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Arrowhead...

Yahoo | January 24, 2023

How should investors view Arrowhead Pharmaceuticals Inc. (ARWR)?

As of Wednesday, Arrowhead Pharmaceuticals Inc.’s (NASDAQ:ARWR) stock closed at $35.99, down from $36.91 the previous day. While Arrowhead Pharmaceuticals Inc. has underperformed by -2.49%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ARWR fell by -37.74%, with highs and lows ranging from $56.47 to $26.81, […]

US Post News | January 19, 2023

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR): It’s all about numbers this morning

Arrowhead Pharmaceuticals Inc. (ARWR)’s stock has witnessed a price hike of 4.29% from the previous close with its current price standing at $31.58. Its current price is -48.44% under its 52-week high of $61.25 and 17.79% more than its 52-week low of $26.81. Based on the past 30-day period, the stock price is -23.52% below […]

US Post News | January 10, 2023

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR): The Stock For Success Over The Next Few Months

In the last trading session, 3.49 million Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) shares changed hands as the company’s beta touched 1.10. With the company’s per share price at $30.28 changed hands at -$7.1 or -18.99% during last session, the market valuation stood at $3.18B. ARWR’s last price was a discount, traded about -105.58% off its 52-week … Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR): The Stock For Success Over The Next Few Months Read More »

Marketing Sentinel | January 10, 2023

Read More 'ARWR' Stories Here

ARWR Price Returns

1-mo -16.23%
3-mo -6.30%
6-mo -19.54%
1-year -32.90%
3-year -23.68%
5-year 444.73%
YTD -17.14%
2022 -38.82%
2021 -13.59%
2020 20.97%
2019 410.71%
2018 237.50%

Continue Researching ARWR

Here are a few links from around the web to help you further your research on Arrowhead Pharmaceuticals Inc's stock as an investment opportunity:

Arrowhead Pharmaceuticals Inc (ARWR) Stock Price | Nasdaq
Arrowhead Pharmaceuticals Inc (ARWR) Stock Quote, History and News - Yahoo Finance
Arrowhead Pharmaceuticals Inc (ARWR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7039 seconds.